Need for Liver Transplants Is Decreasing With New Hep C Drugs
New drugs could eliminate need for liver transplants in some patients
A handful of Canadian patients with hepatitis C have been removed from liver transplant waiting lists thanks to expensive new drug treatments that have stopped the potentially deadly disease from spreading.
Around 20 patients have been removed from Canada’s liver transplant waiting lists, according to surveys collected by Dr. Paul Marotta, a liver specialist at London Health Sciences Centre.
Continue reading this entire article:
New Study Debunks Negative Hep C Stigma
Turmeric for Hepatitis C, and Beyond